Article Sidebar

Download
PDF
Statistic
Read Counter : 114 Download : 166

Main Article Content

Abstract

Neonatal hyperbilirubinemia results from a readiness for the bilirubin production in neonates and limited their ability to excrete it. The diagnosis of hyperbilirubinemia based on yellow discoloration of the skin and whiteness of eyes, idle in the child's movement and the lack of lactation. The baby seems sick or is difficult to awaken. Serum cystatin-C, is a low molecular protein that belongs to the family of cysteine protease inhibitor, was proposed as an endogenous filtration marker. In this study sixty neonatal patients suffering from hyperbilirubinemia (35 males,25female) were collected from prematurity unit (PU) in Al-Zahra Educational Hospital/Al-Najaf Al-Ashraf during the period from August,2020 to February,2021. A group of 20 randomly (12male, 8female) selected apparently healthy group. After diagnosis of hyperbilirubinemia, the patients were divided into three groups according to age (1-3), (4-7) and (7-9) days.  The result reveals that significant increase (p<0.05) in serum cystatin-C in neonatal hyperbilirubinemia as compared with healthy group. The result of study reveals no significant increase(p<0.05) in serum levels of cystatin-C, while the study shows a significant increase (p<0.05) between male and female in serum levels of bilirubin. 

Keywords

Hyperbilirubinemia TSB cystatin-C

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Aljazaeri, S. A. (2021). Cystatin-C as Novel Marker of Neonatal Hyperbilirubinemia, in Al-Najaf City, Iraq. Medical Science Journal for Advance Research, 2(2), 64–70. https://doi.org/10.46966/msjar.v2i2.21
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Abrahamson, M.; Olafsson, I.; Plasdottir, A.; Ulvsback, M.; Lund Wall, A.; Tensson, O. and Grubb, A., (1990). Structure and expression of the human cystatin C gene. Biochem J.,268(2): 287-94.
  2. Astor, B.C.; Levey, A.S.; Stevens, L.A.; Van, L.F.; Selvin, E. and Coresh, J., (2009). Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol., 20(10):2214-2222.
  3. Bertram, JF. ; Douglas-Denton, RN. ; Diouf, B. ; Hughson, MD. and Hoy, WE. , (2011). Human nephron number: implications for health and disease. Pediatr Nephrol., 26(9): 1529-1533.
  4. Cepeda, J.; Tranche-Iparraguirre, S.; Marín-Iranzo, R.; Rodriguez, E.F.; Garcia, A.R.; Casas, J.G. and Rodriguez, E.H., (2010). Cystatin C and Cardiovascular Risk in the General Population Revista Espanola Cardiologia. Revista EDC., 63(4): 415-22.
  5. Charlton, JR.; Portillaand, D. and Okusa, MD., (2013). A basic science view of acute kidney injury biomarkers". Nephrol Dial Transplant, 29(7): 1301-1311.
  6. Chen, JM.; Dando, PM.; Rawlings, ND.; Brown, MA.; Young, NE.; Stevens, RA.; Hewitt, E.: Watts, C.; Barrett AJ., (1997). Cloning, isolation and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem., 272(12):8090-8.
  7. Christine, A.; Whitea Greg A.; Knoll Emilio and Poggio, D., (2010). Measuring vs estimating glomerular filtration rate in kidney transplantation. Transplantation Reviews, 24(1):18–27.
  8. Coll, E. ;Botey, A. ;Alvarez, L.; Poch, E.; Quinto, L.; Saurina, A. ; Vera, M. ; Piera, C. and Darnell, A.,(2000). Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis., 36(1):29–34.
  9. Cui, Y.; Konig, J.; Leier, I.; Buchholz, U. and Keppler, D., (2001). Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem., 276(13): 9626-30.
  10. Filler, G.; Bfkenkamp A.; Hofmann, W.; Le Bricon T.; Martínez-Brú, C. and Grubb, A., (2004). Cystatin C as a marker of GFR—history, indications, and future research. Clinical Biochemistry ,38(1):1-8.
  11. Finney, H.; Newman, DJ. and Price CP., (2000). Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem.,37(1):49-59.
  12. Grubb A., (2000). Cystatin C-properties and use as diagnostic marker. Adv Clin Chem.,35:63-99.
  13. Huang, L. ; Bao, Y. ; Xu, Z. ; Lei, X. ; Chen, Y. ;Zhang, Y. ; Zhang, J. , (2013). Neonatal bilirubin levels and childhood asthma in the US Collaborative Perinatal Project, 1959–1965. Am J Epidemiol. 178(12):1691–1697.
  14. Hung, LH.; Huong, NT. and An, NTT., (2015). Jaundice in Adult In-Patients at a Tertiary General Hospital. Journal of Biosciences and Medicines,3(2):1-11.
  15. Kaplan, M.; Hammerman C., (2002). Glucose-6- phosphate dehy- drogenase deficiency: a potential source of severe neonatal hyper- bilirubinaemia and kernicterus. Semin Neonatol.,7(2):121–128.
  16. Kazuo, U.; Akiko, G., (2002). Measurement of cystatin-C and creatinine in urine. Clinica Chimica Acta., 323(1-2):121–128.
  17. Kraingkrai, P.; Norio, T.; Kate, G.; Shoji, M. and Tadao, S., (2011). Simultaneous injection effective mixing analysis system for the determination of direct bilirubin in urinary samples. Talanta, 87(15) :113-117.
  18. Luyckx, VA.; Brenner, BM., (2010). The clinical importance of nephron mass. J Am Soc Nephrol., 21(6): 898–910
  19. Maria, C.P. Franco; Sônia K. Nishida and Sesso, R., (2008). GFR Estimated from Cystatin C Versus Creatinine in Children Born Small for Gestational Ag. American Journal of Kidney Diseases, 51(6): 925-932.
  20. National Institute for Health and Clinical Excellence (NIHCE), (2010). Neonatal jaundice. CG98. London: National Insititute for Health and Clinical Excellence.
  21. Qiang, L.; Fang, J.Y.; Wang, W.P.; Liu, J.H. and Wang, K.K., (2010). Cystatin C and serum creatinine in estimating acute kidney injury of shock patients. World J Emerg Med., 1(3):185-189.
  22. Rule, A.D.; Bergstralh, E.J.; Slezak, J.M.; Bergert, J. and Larson, T.S., (2006). Glomerular Filtration Rate Estimated by Cystatin C among Different Clinical Presentations. Kidney International, 69(2): 399-405.
  23. Salgado, J.V.; França, A.K.; Cabral, N.A.; Lages, J.; Ribeiro, V.S.; Santos, A.M. and Salgado, B.J., (2013). Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. Revista da Associação Médica Brasileira., 59 (1): 21-27.
  24. Shlipak, M.G.; Sarnak, M.J; Katz, R.; Fried, L. F, Seliger, S. L.; Newman, A. B.; Siscovick, D. S. and Stehman - Breen, C., (2005). Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med., 352(20):2049-2060.
  25. Stevens, L.A. ; Schmid, C.H. ; Greene, T. ; Li, L. ; Beck, G.J. ; Joffe, MM.; Froissart, M. ; Kusek, JW. ; Zhang, YL. ; Coresh, J. and Levey, AS. , (2009) . Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int., 75(6):652-660.
  26. Wang, P.; Kim, RB.; Chowdhury, JR. and Wolkoff, AW., (2003). The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem., 278(23): 20695e9.
  27. Watchko, J.F.; Maisels, MJ., (2003). Jaundice in low birthweight Infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 88(6): 455-458.
  28. Woodgate, P.; Jardine, L.A., (2011). Neonatal jaundice. BMJ: Clinical Evidence, 09:319.
  29. Young Infants Clinical Signs Study Group (YICSSG), (2008). Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet., 371 (9607):135-42.
  30. Zhang, G.M.; Xia, Y.J.; Guo, X.X.; Zhu, B.L.; Zhang, G.M. et al., (2014). Reference Intervals of Total Bilirubin, ALT, AST, and Creatinine in Healthy Elderly Chinese. Med Sci Monit., 20: 1778-1782.